Pharmaceutical composition containing FGF21 mutant fusion protein and method for treating hepatitis, hepatic fibrosis, and hepatic cirrhosis
A fusion protein containing a biologically active protein and an FGF21 mutant protein, a pharmaceutical composition containing the fusion protein, and their uses are disclosed. The fusion protein and the pharmaceutical composition are effective in treating a liver disease including hepatitis, hepati...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Kim, Taewang Oh, Se Woong Kim, Jun Hwan Song, Moo Young Hong, Han Na Choi, Hyun Ho Kim, Jong Gyun Kim, Dohoon |
| description | A fusion protein containing a biologically active protein and an FGF21 mutant protein, a pharmaceutical composition containing the fusion protein, and their uses are disclosed. The fusion protein and the pharmaceutical composition are effective in treating a liver disease including hepatitis, hepatic fibrosis, and hepatic cirrhosis. The fusion protein has effects of inhibiting proliferation of inflammatory cells and fibroblasts, and thus can be effectively used for treating hepatitis, hepatic fibrosis, and hepatic cirrhosis. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US11179440B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US11179440B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US11179440B23</originalsourceid><addsrcrecordid>eNqNjrsKAjEQRbexEPUfxl7BrILYKq6WglovMTsxA5sHyexf-NEmsPZWczh37jDT6nMzMlqpcGBSsgflbfCJmLzL7FiSI_eG5tLUAuzA0jHoIZU4RM9IDqTrwCIb34H2ETii5NIxGDIwpdWICjS9Yr6eTSn9rKIYTdHzaqJln3Axzlm1bM6P03WNwbeYQn7TIbfPuxBif9jtNsd6-8_OF15pTiQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Pharmaceutical composition containing FGF21 mutant fusion protein and method for treating hepatitis, hepatic fibrosis, and hepatic cirrhosis</title><source>esp@cenet</source><creator>Kim, Taewang ; Oh, Se Woong ; Kim, Jun Hwan ; Song, Moo Young ; Hong, Han Na ; Choi, Hyun Ho ; Kim, Jong Gyun ; Kim, Dohoon</creator><creatorcontrib>Kim, Taewang ; Oh, Se Woong ; Kim, Jun Hwan ; Song, Moo Young ; Hong, Han Na ; Choi, Hyun Ho ; Kim, Jong Gyun ; Kim, Dohoon</creatorcontrib><description>A fusion protein containing a biologically active protein and an FGF21 mutant protein, a pharmaceutical composition containing the fusion protein, and their uses are disclosed. The fusion protein and the pharmaceutical composition are effective in treating a liver disease including hepatitis, hepatic fibrosis, and hepatic cirrhosis. The fusion protein has effects of inhibiting proliferation of inflammatory cells and fibroblasts, and thus can be effectively used for treating hepatitis, hepatic fibrosis, and hepatic cirrhosis.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211123&DB=EPODOC&CC=US&NR=11179440B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76553</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211123&DB=EPODOC&CC=US&NR=11179440B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Kim, Taewang</creatorcontrib><creatorcontrib>Oh, Se Woong</creatorcontrib><creatorcontrib>Kim, Jun Hwan</creatorcontrib><creatorcontrib>Song, Moo Young</creatorcontrib><creatorcontrib>Hong, Han Na</creatorcontrib><creatorcontrib>Choi, Hyun Ho</creatorcontrib><creatorcontrib>Kim, Jong Gyun</creatorcontrib><creatorcontrib>Kim, Dohoon</creatorcontrib><title>Pharmaceutical composition containing FGF21 mutant fusion protein and method for treating hepatitis, hepatic fibrosis, and hepatic cirrhosis</title><description>A fusion protein containing a biologically active protein and an FGF21 mutant protein, a pharmaceutical composition containing the fusion protein, and their uses are disclosed. The fusion protein and the pharmaceutical composition are effective in treating a liver disease including hepatitis, hepatic fibrosis, and hepatic cirrhosis. The fusion protein has effects of inhibiting proliferation of inflammatory cells and fibroblasts, and thus can be effectively used for treating hepatitis, hepatic fibrosis, and hepatic cirrhosis.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjrsKAjEQRbexEPUfxl7BrILYKq6WglovMTsxA5sHyexf-NEmsPZWczh37jDT6nMzMlqpcGBSsgflbfCJmLzL7FiSI_eG5tLUAuzA0jHoIZU4RM9IDqTrwCIb34H2ETii5NIxGDIwpdWICjS9Yr6eTSn9rKIYTdHzaqJln3Axzlm1bM6P03WNwbeYQn7TIbfPuxBif9jtNsd6-8_OF15pTiQ</recordid><startdate>20211123</startdate><enddate>20211123</enddate><creator>Kim, Taewang</creator><creator>Oh, Se Woong</creator><creator>Kim, Jun Hwan</creator><creator>Song, Moo Young</creator><creator>Hong, Han Na</creator><creator>Choi, Hyun Ho</creator><creator>Kim, Jong Gyun</creator><creator>Kim, Dohoon</creator><scope>EVB</scope></search><sort><creationdate>20211123</creationdate><title>Pharmaceutical composition containing FGF21 mutant fusion protein and method for treating hepatitis, hepatic fibrosis, and hepatic cirrhosis</title><author>Kim, Taewang ; Oh, Se Woong ; Kim, Jun Hwan ; Song, Moo Young ; Hong, Han Na ; Choi, Hyun Ho ; Kim, Jong Gyun ; Kim, Dohoon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US11179440B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Kim, Taewang</creatorcontrib><creatorcontrib>Oh, Se Woong</creatorcontrib><creatorcontrib>Kim, Jun Hwan</creatorcontrib><creatorcontrib>Song, Moo Young</creatorcontrib><creatorcontrib>Hong, Han Na</creatorcontrib><creatorcontrib>Choi, Hyun Ho</creatorcontrib><creatorcontrib>Kim, Jong Gyun</creatorcontrib><creatorcontrib>Kim, Dohoon</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Kim, Taewang</au><au>Oh, Se Woong</au><au>Kim, Jun Hwan</au><au>Song, Moo Young</au><au>Hong, Han Na</au><au>Choi, Hyun Ho</au><au>Kim, Jong Gyun</au><au>Kim, Dohoon</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Pharmaceutical composition containing FGF21 mutant fusion protein and method for treating hepatitis, hepatic fibrosis, and hepatic cirrhosis</title><date>2021-11-23</date><risdate>2021</risdate><abstract>A fusion protein containing a biologically active protein and an FGF21 mutant protein, a pharmaceutical composition containing the fusion protein, and their uses are disclosed. The fusion protein and the pharmaceutical composition are effective in treating a liver disease including hepatitis, hepatic fibrosis, and hepatic cirrhosis. The fusion protein has effects of inhibiting proliferation of inflammatory cells and fibroblasts, and thus can be effectively used for treating hepatitis, hepatic fibrosis, and hepatic cirrhosis.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US11179440B2 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Pharmaceutical composition containing FGF21 mutant fusion protein and method for treating hepatitis, hepatic fibrosis, and hepatic cirrhosis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-09T20%3A15%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Kim,%20Taewang&rft.date=2021-11-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS11179440B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |